|
|
Résultats pour
brevets
1.
|
Vaccine composition and method of preventing porcine epidemic diarrhea virus infection in swine
| Numéro d'application |
17000377 |
| Numéro de brevet |
11413347 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2020-08-24 |
| Date de la première publication |
2021-03-04 |
| Date d'octroi |
2022-08-16 |
| Propriétaire |
Reber Genetics Co., Ltd. (Taïwan, Province de Chine)
|
| Inventeur(s) |
- Chang, Chia-Jung
- Chang, Jen-Yu
- Yang, Cheng-Xin
|
Abrégé
A vaccine composition includes a porcine epidemic diarrhea virus (PEDV) S1 spike protein having an amino acid sequence of SEQ ID NO: 1, and an inactivated porcine epidemic diarrhea virus (PEDV). The vaccine composition is used in a method of preventing PEDV infection in swine, whereby systemic Immunoglobulin G (IgG), Immunoglobulin A (IgA) and neutralizing antibody may be successfully induced by the vaccine composition, hence providing sufficient immune protection against PEDV.
Classes IPC ?
- A61K 39/225 - Virus de la gastro-entérite transmissible du porc
- C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
- A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
- A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
|
2.
|
Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
| Numéro d'application |
15167911 |
| Numéro de brevet |
10010602 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2016-05-27 |
| Date de la première publication |
2016-12-01 |
| Date d'octroi |
2018-07-03 |
| Propriétaire |
REBER GENETICS CO., LTD. (Taïwan, Province de Chine)
|
| Inventeur(s) |
- Chien, Yu-Hsin
- Tsai, Meng-Ju
- Lai, Pao-Yen
- Chou, Wei-I
- Chang, Hsiu-Kang
|
Abrégé
A fusion protein comprising an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a translocation peptide, a fusion antigen, an endoplasmic reticulum retention sequence, and optionally a nuclear export signal is disclosed. The fusion antigen comprises a porcine reproductive and respiratory syndrome virus (PRRSV) ORF7 antigen, a PRRSV ORF1b antigen, a PRRSV ORF6 antigen, and a PRRSV ORF5 antigen. The fusion protein is useful for inducing antigen-specific cell-mediated and humoral responses.
Classes IPC ?
- A61K 39/12 - Antigènes viraux
- C07K 14/005 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de virus
- C07K 14/21 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Pseudomonadaceae (F)
- A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
|
3.
|
Baculovirus display vectors and uses thereof
| Numéro d'application |
15153851 |
| Numéro de brevet |
10172931 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2016-05-13 |
| Date de la première publication |
2016-11-17 |
| Date d'octroi |
2019-01-08 |
| Propriétaire |
REBER GENETICS CO., LTD. (Taïwan, Province de Chine)
|
| Inventeur(s) |
- Chang, Chia-Jung
- Liao, Yan-Chiou
- Chou, Wei-I
- Chang, Hsiu-Kang
|
Abrégé
A recombinant baculovirus displaying on its envelop a fusion protein is disclosed. The fusion protein comprises a heterologous antigen, and a C-terminal region of baculovirus envelope GP64 protein, which has at least 100 amino acid residues in length and lacks a B12D5 binding epitope located within the central basic region of the GP64 protein. The genome of the recombinant baculovirus comprises a transgene encoding a fusion protein that comprises a signal peptide, the heterologous antigen, and the C-terminal region of the baculovirus envelope GP64 protein, in which the antigen is located between the signal peptide and the C-terminal region of the GP64 protein. Methods for eliciting an antigen-specific immunogenic response in a subject in need thereof are also disclosed.
Classes IPC ?
- C07K 14/005 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de virus
- A61K 39/12 - Antigènes viraux
|
|